Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantation.
作者:
主题词
急性病(Acute Disease);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);卡莫司汀(Carmustine);阿糖胞苷(Cytarabine);依托泊甙(Etoposide);致命性结局(Fatal Outcome);疾病遗传易感性(Genetic Predisposition to Disease);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);造血干细胞动员(Hematopoietic Stem Cell Mobilization);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);白血病, 髓样(Leukemia, Myeloid);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤, 残余(Neoplasm, Residual);肿瘤, 多原发性(Neoplasms, Multiple Primary);肿瘤, 继发原发性(Neoplasms, Second Primary);重组蛋白质类(Recombinant Proteins);危险(Risk);吸烟(Smoking);移植预处理(Transplantation Conditioning);移植, 自体(Transplantation, Autologous);阿糖腺苷(Vidarabine)
DOI
10.1023/a:1026505632679
PMID
11142491
发布时间
2020-02-03
- 浏览7

Annals of oncology
1493-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文